GLP-1 Medications: The Complete Guide to Semaglutide and Tirzepatide

What is a GLP-1 Receptor Agonist?

GLP-1 stands for glucagon-like peptide-1, a hormone naturally produced in your gut after eating. It signals your brain that you're full, slows gastric emptying so food stays in your stomach longer, and regulates blood sugar by stimulating insulin release. GLP-1 receptor agonists are medications that mimic and amplify this hormone's effects.

The reason these medications work so powerfully is that obesity is fundamentally a biological condition, not a failure of discipline. Many people with obesity have dysregulated satiety signaling. GLP-1 medications correct this at the hormonal level, making it physically easier to eat less without the relentless hunger that derails most diets.

Semaglutide vs. Tirzepatide: What's the Difference?

Semaglutide (the active ingredient in branded GLP-1 medications and branded GLP-1 medications) is a GLP-1 receptor agonist approved for both type 2 diabetes and chronic weight management. It activates one receptor — the GLP-1 receptor — to produce its effects. In the landmark STEP 1 trial, participants lost an average of 14.9% of their body weight over 68 weeks.

Tirzepatide tirzepatide is what researchers call a "dual agonist" — it activates both the GLP-1 receptor and a second receptor called GIP (glucose-dependent insulinotropic polypeptide). This dual mechanism produces stronger weight loss. In the SURMOUNT-1 trial, participants lost an average of 20.9% of body weight at the highest dose.

Side-by-Side Comparison

• Semaglutide: Weekly injection, activates GLP-1 receptor, average 15% weight loss, longer track record of safety data
• Tirzepatide: Weekly injection, activates GLP-1 + GIP receptors, average 20–22% weight loss, more recent approval
• Both: Require physician prescription, compounded versions available through licensed pharmacies, administered by subcutaneous injection

Who Qualifies for GLP-1 Treatment?

GLP-1 medications are clinically indicated for adults who meet one of the following criteria:

• BMI of 30 or higher (obesity), or
• BMI of 27 or higher (overweight) with at least one weight-related condition such as type 2 diabetes, high blood pressure, or high cholesterol

During your telehealth consultation, your physician will review your health history, current medications, and any contraindications. GLP-1 medications are not appropriate for patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.

What Results Can You Expect?

Most patients notice reduced appetite within the first 1–2 weeks. Meaningful weight loss typically begins in weeks 4–8. The medication is titrated (dose increased) gradually over several months to minimize side effects and maximize results.

A realistic timeline for most patients: by month 3, 8–10% body weight lost; by month 6, 12–15%; by month 12, 15–22% depending on medication and individual response. Results are significantly better when combined with modest lifestyle changes — not dramatic diets, but sustainable habits.

Common Side Effects and How to Manage Them

The most commonly reported side effects are gastrointestinal: nausea, mild vomiting, constipation, or diarrhea. These are most pronounced when starting the medication or increasing the dose, and typically resolve within 1–2 weeks as your body adjusts.

• Nausea: Take medication at bedtime, eat smaller meals, avoid high-fat or spicy foods
• Constipation: Increase water intake and fiber; your physician can recommend osmotic laxatives if needed
• Fatigue: Common early on, typically resolves within weeks 2–4

Serious side effects are rare. Contact your provider immediately if you experience severe abdominal pain, persistent vomiting, or any vision changes.

GLP-1 + Hormone Optimization: A Powerful Combination

One of the challenges with significant weight loss is muscle loss. When patients lose large amounts of weight rapidly, a portion of that loss can be lean muscle mass — which slows metabolism and reduces long-term success. This is why many of our patients combine GLP-1 therapy with testosterone optimization or hormone support, which helps preserve muscle while maximizing fat loss. The combination produces dramatically better body composition outcomes than either treatment alone.